Pedro Cascales. Hospital Clínico Universitario Virgen de la Arrixaca. Murcia, Spain

• An update on treatment of peritoneal metastasis of endometrial cancer and rare histologies of epithelial ovarian cancer (clear cell, mucinous adenocarcinoma, carcinosarcoma)
• When and how to surgically treat recurrent ovarian cancer? From selection criteria to use of HIPEC
  Jean Marc Classe. Institut de Cancérologie de l’Ouest, Nantes, France
• Less is more or more is more? Surgical decision-making during interval cytoreduction of ovarian cancer treated with neoadjuvant chemotherapy
• Does PIPAC have a role in the management of recurrent, unresectable peritoneal metastases of ovarian cancer?
  Thanh Dellinger. City of Hope Comprehensive Cancer Center. California, USA